3.0.0 7567 2023-01-11T13:45:58Z 2023-01-11T13:45:58Z House HR 2020-07-09 116 [Congressional Record Volume 166, Number 125 (Monday, July 13, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. TONKO:H.R. 7567.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3[Submitted July 13, 2020][Page H3083]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-07-09T18:04:15Z 2020-07-09 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-07-09 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-07-09 Introduced in House IntroReferral 1000 9 Library of Congress T000469 Rep. Tonko, Paul [D-NY-20] Paul Tonko D NY 20 N M001180 Rep. McKinley, David B. [R-WV-1] David McKinley R WV B. 1 2020-07-09 True S001204 Del. San Nicolas, Michael F. Q. [D-GU-At Large] Michael San Nicolas D GU F. Q. 0 2020-09-01 False Health Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy European Union Government information and archives Government studies and investigations Health care coverage and access Health information and medical records Licensing and registrations Prescription drugs Health 00 2020-07-09 Introduced in House 2021-01-28T15:30:52Z Helping Experts Accelerate Rare Treatments Act of 2020

This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.

The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as orphan drugs if the rarity of the disease makes it difficult for the drug to be profitable).

]]> Helping Experts Accelerate Rare Treatments Act of 2020 Display Title Helping Experts Accelerate Rare Treatments Act of 2020 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes. Introduced in House IH Short Title(s) as Introduced Helping Experts Accelerate Rare Treatments Act of 2020 Introduced in House IH Introduced in House 2020-07-09T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr7567ih/xml/BILLS-116hr7567ih.xml 2020-07-09 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.